Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$190M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$178M |
| 3 |
Meta Platforms (Facebook)
META
|
+$172M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$169M |
| 5 |
Microsoft
MSFT
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$278M |
| 2 |
Intel
INTC
|
+$223M |
| 3 |
PPLI
People Inc
PPLI
|
+$210M |
| 4 |
Mastercard
MA
|
+$210M |
| 5 |
Honeywell
HON
|
+$188M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.18% |
| 2 | Consumer Discretionary | 6.93% |
| 3 | Technology | 6.31% |
| 4 | Industrials | 5.82% |
| 5 | Financials | 5.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
iShares MSCI Israel ETF
EIS
$886M
| $336 | ﹤0.01% |
6,400
+176
| +3% | +$9.53K |
|
3727
Lineage Cell Therapeutics
LCTX
$276M
| $335 | ﹤0.01% |
357,528
+343,328
| +2,418% | +$303K |
|
3728
Lands' End
LE
$377M
| $335 | ﹤0.01% |
+25,711
| New | +$289K |
|
|
OTRK
3729
DELISTED
Ontrak
OTRK
| $335 | ﹤0.01% |
62
-115
| -65% | -$532K |
|
3730
Airgain
AIRG
$68.4M
| $333 | ﹤0.01% |
+24,990
| New | +$321K |
|
3731
iShares S&P 500 Growth ETF
IVW
$75.6B
| $333 | ﹤0.01% |
5,772
-43,560
| -88% | -$2.47M |
|
|
AVNS
3732
CALL
DELISTED
Avanos Medical
AVNS
| $332 | ﹤0.01% |
+10,000
| New | +$320K |
|
3733
ICICI Bank
IBN
$106B
| $331 | ﹤0.01% |
33,723
-17,976
| -35% | -$179K |
|
3734
Tompkins Financial
TMP
$1.41B
| $331 | ﹤0.01% |
5,828
-6,553
| -53% | -$417K |
|
3735
Murphy Oil
MUR
$5.16B
| $329 | ﹤0.01% |
+36,925
| New | +$474K |
|
3736
Standex International
SXI
$3.67B
| $329 | ﹤0.01% |
5,556
-54,493
| -91% | -$3.13M |
|
|
TARO
3737
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $329 | ﹤0.01% |
5,991
+1,215
| +25% | +$75.6K |
|
|
XXII
3738
22nd Century Group
XXII
$2.63M
| – | – |
0
| – | – |
|
3739
Saratoga Investment
SAR
$297M
| $327 | ﹤0.01% |
+19,453
| New | +$332K |
|
|
MTLS
3740
Materialise
MTLS
$387M
| $326 | ﹤0.01% |
+8,831
| New | +$270K |
|
3741
Origin Bancorp
OBK
$1.64B
| $326 | ﹤0.01% |
15,255
-86,454
| -85% | -$1.93M |
|
3742
Phunware
PHUN
$42.6M
| $326 | ﹤0.01% |
7,135
-957
| -12% | -$58.7K |
|
|
LHCG
3743
DELISTED
LHC Group LLC
LHCG
| $326 | ﹤0.01% |
1,533
-47,131
| -97% | -$9.3M |
|
|
IOR
3744
Income Opportunity Realty Investors
IOR
| $325 | ﹤0.01% |
+27,468
| New | +$360K |
|
3745
CALL
Mercado Libre
MELI
$98.8B
| $325 | ﹤0.01% |
+300
| New | +$326K |
|
|
AMNB
3746
DELISTED
American National Bankshares Inc
AMNB
| $325 | ﹤0.01% |
+15,558
| New | +$353K |
|
3747
Benchmark Electronics
BHE
$2.58B
| $324 | ﹤0.01% |
16,078
-4,791
| -23% | -$97.4K |
|
3748
CALL
Royal Gold
RGLD
$22.3B
| $324 | ﹤0.01% |
+2,700
| New | +$355K |
|
|
3749
PUT
Royal Gold
RGLD
$22.3B
| $324 | ﹤0.01% |
+2,700
| New | +$355K |
|
|
VRS
3750
DELISTED
Verso Corporation
VRS
| $324 | ﹤0.01% |
+41,096
| New | +$500K |
|
Similar funds
Israel Englander's Q3 2020 Portfolio in Review
As of Q3 2020, Israel Englander held 5,106 positions worth $81.2M, down 100% from $73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $869M of net new capital in Q3 2020, opening 989 new positions and adding to 1,503 existing holdings. Its largest new stake was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
By sector, the portfolio is most concentrated in Healthcare at 9.2% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $278M trimmed.
- Israel Englander's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
- Israel Englander added most to Varian Medical Systems, Inc. in Q3 2020, an estimated $190M increase.
- Israel Englander's biggest Q3 2020 reduction was JPMorgan Chase, cutting an estimated $278M.
- Israel Englander fully exited Tech Data Corp in Q3 2020, selling an estimated $186M.
- Israel Englander's ten largest holdings make up 18% of its $81.2M portfolio in Q3 2020.
- Israel Englander opened 989 new positions and closed 724 in Q3 2020.
- Israel Englander's portfolio value fell 100% quarter-over-quarter to $81.2M.
Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.